Epithelial Basement Membrane

The epithelial basement membrane is a specialized structural extracellular matrix (ECM) component, not a discrete molecular entity or traditional therapeutic target. It is a layered cell-adherent extracellular matrix that forms part of tissue architecture, composed of multiple protein components including laminin, type IV collagen, nidogen, and proteoglycans. It provides structural support, establishes cell polarity, serves as a permeability barrier, and mediates cell signaling. It is a composite assembly of multiple protein molecules organized into a supramolecular architecture, whose composition and organization varies by tissue type. It is not a single molecule or receptor that drugs can directly bind, nor is it an appropriate target for conventional drug development approaches as a whole structure. If drug development targets basement membrane dysfunction, the focus would typically be on individual component proteins (e.g., specific laminin isoforms, type IV collagen, collagen XVII) or cellular receptors that interact with it (e.g., integrin receptors like \u03b16\u03b24, \u03b13\u03b11, \u03b12\u03b21).

Other names

Basement MembraneECM component